MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 4.220
-0.040 (-0.94%)
Sep 9, 2026, 1:43 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.22 billion as of September 8, 2026. Its market cap has increased by 5.64% in one year.
Market Cap
2.22B
Enterprise Value
2.37B
Revenue
584.74M
Ranking
n/a
PE Ratio
70.53
Stock Price
4.22
ChartMarket Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.22B, a decrease of -49.27%. That is a compound annual growth rate of -23.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 2.22B | -8.82% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 549.12B |
| Lin BioScience | 144.70B |
| Caliway Biopharmaceuticals | 132.52B |
| Pell Bio-Med Technology | 79.15B |
| PhytoHealth | 2.22B |
| Taiwan Bio Therapeutics | 2.21B |
| MedFirst Healthcare Services | 2.18B |
| HeXun Biosciences | 2.15B |